Dr. Nick Oberheiden of Oberheiden P.C. has been named a Go-To Thought Leader for his coverage of the US federal government’s various actions related to healthcare fraud.  Dr. Oberheiden provided valuable insight into the federal government’s new enforcement effort into amniotic fluid injections, detailing how the treatment may be subject to investigation for fraud and scientific legitimacy by CMS and the US Department of Justice and saw considerable readership throughout the year.